NCT03836716 Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial Status TERMINATED Phase PHASE3
NCT03835507 Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis Status RECRUITING Phase PHASE1/PHASE2
NCT03806647 Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1) Status UNKNOWN Phase N/A
NCT03806634 Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2) Status UNKNOWN Phase N/A
NCT03793868 Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis Status COMPLETED Phase EARLY_PHASE1
NCT03792490 Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS Status COMPLETED Phase PHASE2
NCT03766321 Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT03757351 Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1
NCT03705390 A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT03694132 Brain Excitability and Connectivity in Sensory-motor Pathways in ALS Status COMPLETED Phase NA
NCT03690791 Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease Status UNKNOWN Phase PHASE3
NCT03683875 Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral Sclerosis Status COMPLETED Phase N/A
NCT03679975 Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT03664206 Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy Status WITHDRAWN Phase N/A
NCT03659422 Dietary Approach to Improving Quality of Life in Amyotrophic Lateral Sclerosis Status WITHDRAWN Phase NA